{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:12Z","timestamp":1790553612558,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81704099"],"award-info":[{"award-number":["81704099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673436"],"award-info":[{"award-number":["81673436"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91853109"],"award-info":[{"award-number":["91853109"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872877"],"award-info":[{"award-number":["81872877"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81730100"],"award-info":[{"award-number":["81730100"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Bony fusion caused by pathological new bone formation manifests the clinical feature of ankylosing spondylitis (AS). However, the underlying mechanism remains elusive. Here we discovered spontaneous kyphosis, arthritis and bony fusion in mature CD4-Cre;<jats:italic>Ptpn11<\/jats:italic>\n            <jats:sup>f\/f<\/jats:sup> mice, which present the pathophysiological features of AS. A population of CD4-Cre-expressing proliferating chondrocytes was SHP2 deficient, which could differentiate into pre-hypertrophic and hypertrophic chondrocytes. Functionally, SHP2 deficiency in chondrocytes impeded the fusion of epiphyseal plate and promoted chondrogenesis in joint cavity and enthesis. Mechanistically, aberrant chondrocytes promoted ectopic new bone formation through BMP6\/pSmad1\/5 signaling. It is worth emphasizing that such pathological thickness of growth plates was evident in adolescent humans with enthesitis-related arthritis, which could progress to AS in adulthood. Targeting dysfunctional chondrogenesis with Smo inhibitor sonidegib significantly alleviated the AS-like bone disease in mice. These findings suggest that blockade of chondrogenesis by sonidegib would be a drug repurposing strategy for AS treatment.<\/jats:p>","DOI":"10.1038\/s41467-021-26750-6","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T11:06:09Z","timestamp":1636628769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Targeting chondrocytes for arresting bony fusion in ankylosing spondylitis"],"prefix":"10.1038","volume":"12","author":[{"given":"Fenli","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6885-4083","authenticated-orcid":false,"given":"Yuyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen-Sheng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiguo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1425-0089","authenticated-orcid":false,"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"key":"26750_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","volume":"390","author":"J Sieper","year":"2017","unstructured":"Sieper, J. & Poddubnyy, D. Axial spondyloarthritis. Lancet 390, 73\u201384 (2017).","journal-title":"Lancet"},{"key":"26750_CR2","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1056\/NEJMra1406182","volume":"374","author":"JD Taurog","year":"2016","unstructured":"Taurog, J. D., Chhabra, A. & Colbert, R. A. Ankylosing spondylitis and axial spondyloarthritis. N. Engl. J. Med 374, 2563\u20132574 (2016).","journal-title":"N. Engl. J. Med"},{"key":"26750_CR3","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/ng.2667","volume":"45","author":"A Cortes","year":"2013","unstructured":"Cortes, A. et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat. Genet 45, 730\u2013738 (2013).","journal-title":"Nat. Genet"},{"key":"26750_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s11926-006-0061-z","volume":"8","author":"K de Vlam","year":"2006","unstructured":"de Vlam, K., Lories, R. J. & Luyten, F. P. Mechanisms of pathologic new bone formation. Curr. Rheumatol. Rep. 8, 332\u2013337 (2006).","journal-title":"Curr. Rheumatol. Rep."},{"key":"26750_CR5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/art.39298","volume":"68","author":"MM Ward","year":"2016","unstructured":"Ward, M. M. et al. American college of rheumatology\/spondylitis association of America\/spondyloarthritis research and treatment network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 68, 282\u2013298 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"26750_CR6","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","volume":"373","author":"D Baeten","year":"2015","unstructured":"Baeten, D. et al. Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis. N. Engl. J. Med 373, 2534\u20132548 (2015).","journal-title":"N. Engl. J. Med"},{"key":"26750_CR7","doi-asserted-by":"publisher","first-page":"R439","DOI":"10.1186\/ar1693","volume":"7","author":"X Baraliakos","year":"2005","unstructured":"Baraliakos, X. et al. Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3\u2009years of continuous treatment with infliximab. Arthritis Res. Ther. 7, R439\u2013R444 (2005).","journal-title":"Arthritis Res. Ther."},{"key":"26750_CR8","doi-asserted-by":"publisher","first-page":"R104","DOI":"10.1186\/ar2496","volume":"10","author":"X Baraliakos","year":"2008","unstructured":"Baraliakos, X., Listing, J., Rudwaleit, M., Sieper, J. & Braun, J. The relationship between inflammation and new bone formation in patients with ankylosing spondylitis. Arthritis Res. Ther. 10, R104 (2008).","journal-title":"Arthritis Res. Ther."},{"key":"26750_CR9","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock, J. P. et al. IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells. Nat. Med 18, 1069\u20131076 (2012).","journal-title":"Nat. Med"},{"key":"26750_CR10","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/art.40468","volume":"70","author":"X Li","year":"2018","unstructured":"Li, X. et al. Inflammation intensity-dependent expression of osteoinductive Wnt proteins is critical for ectopic new bone formation in ankylosing spondylitis. Arthritis Rheumatol. 70, 1056\u20131070 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"26750_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1136\/annrheumdis-2011-200208","volume":"71","author":"D van der Heijde","year":"2012","unstructured":"van der Heijde, D. et al. MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis. Ann. Rheum. 71, 369\u2013373 (2012).","journal-title":"Ann. Rheum."},{"key":"26750_CR12","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1002\/art.30393","volume":"63","author":"P Chiowchanwisawakit","year":"2011","unstructured":"Chiowchanwisawakit, P., Lambert, R. G., Conner-Spady, B. & Maksymowych, W. P. Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. Arthritis Rheumatol. 63, 2215\u20132225 (2011).","journal-title":"Arthritis Rheumatol."},{"key":"26750_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nm1538","volume":"13","author":"D Diarra","year":"2007","unstructured":"Diarra, D. et al. Dickkopf-1 is a master regulator of joint remodeling. Nat. Med 13, 156\u2013163 (2007).","journal-title":"Nat. Med"},{"key":"26750_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41413-021-00140-6","volume":"9","author":"T Yu","year":"2021","unstructured":"Yu, T. et al. Chondrogenesis mediates progression of ankylosing spondylitis through heterotopic ossification. Bone Res 9, 19 (2021).","journal-title":"Bone Res"},{"key":"26750_CR15","doi-asserted-by":"publisher","first-page":"R108","DOI":"10.1186\/ar3833","volume":"14","author":"E Klingberg","year":"2012","unstructured":"Klingberg, E. et al. Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment. Arthritis Res. Ther. 14, R108 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"26750_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40674-016-0055-6","volume":"2","author":"AM Hinze","year":"2016","unstructured":"Hinze, A. M. & Louie, G. H. Osteoporosis management in ankylosing spondylitis. Curr. Treat. Options Rheumatol. 2, 271\u2013282 (2016).","journal-title":"Curr. Treat. Options Rheumatol."},{"key":"26750_CR17","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1002\/art.21907","volume":"54","author":"H Appel","year":"2006","unstructured":"Appel, H. et al. Immunohistochemical analysis of hip arthritis in ankylosing spondylitis: evaluation of the bone-cartilage interface and subchondral bone marrow. Arthritis Rheumatol. 54, 1805\u20131813 (2006).","journal-title":"Arthritis Rheumatol."},{"key":"26750_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nature18621","volume":"535","author":"YN Chen","year":"2016","unstructured":"Chen, Y. N. et al. Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases. Nature 535, 148\u2013152 (2016).","journal-title":"Nature"},{"key":"26750_CR19","doi-asserted-by":"publisher","first-page":"10842","DOI":"10.1074\/jbc.RA119.011840","volume":"295","author":"W Liu","year":"2020","unstructured":"Liu, W. et al. Disrupting phosphatase SHP2 in macrophages protects mice from high-fat diet-induced hepatic steatosis and insulin resistance by elevating IL-18 levels. J. Biol. Chem. 295, 10842\u201310856 (2020).","journal-title":"J. Biol. Chem."},{"key":"26750_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41392-021-00474-x","volume":"6","author":"W Liu","year":"2021","unstructured":"Liu, W. et al. SHP2-mediated mitophagy boosted by lovastatin in neuronal cells alleviates parkinsonism in mice. Signal Transduct. Target Ther. 6, 34 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"26750_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02351-0","volume":"8","author":"W Guo","year":"2017","unstructured":"Guo, W. et al. Tyrosine phosphatase SHP2 negatively regulates NLRP3 inflammasome activation via ANT1-dependent mitochondrial homeostasis. Nat. Commun. 8, 2168 (2017).","journal-title":"Nat. Commun."},{"key":"26750_CR22","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nature12396","volume":"499","author":"W Yang","year":"2013","unstructured":"Yang, W. et al. Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling. Nature 499, 491\u2013495 (2013).","journal-title":"Nature"},{"key":"26750_CR23","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/jbmr.2062","volume":"29","author":"HK Kim","year":"2014","unstructured":"Kim, H. K., Feng, G. S., Chen, D., King, P. D. & Kamiya, N. Targeted disruption of Shp2 in chondrocytes leads to metachondromatosis with multiple cartilaginous protrusions. J. Bone Miner. Res. 29, 761\u2013769 (2014).","journal-title":"J. Bone Miner. Res."},{"key":"26750_CR24","doi-asserted-by":"publisher","first-page":"e1004364","DOI":"10.1371\/journal.pgen.1004364","volume":"10","author":"ME Bowen","year":"2014","unstructured":"Bowen, M. E., Ayturk, U. M., Kurek, K. C., Yang, W. & Warman, M. L. SHP2 regulates chondrocyte terminal differentiation, growth plate architecture and skeletal cell fates. PLoS Genet 10, e1004364 (2014).","journal-title":"PLoS Genet"},{"key":"26750_CR25","doi-asserted-by":"publisher","first-page":"E1307","DOI":"10.1097\/BRS.0b013e3182a3d370","volume":"38","author":"HK Kim","year":"2013","unstructured":"Kim, H. K. et al. Induction of SHP2 deficiency in chondrocytes causes severe scoliosis and kyphosis in mice. Spine 38, E1307\u2013E1312 (2013).","journal-title":"Spine"},{"key":"26750_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41413-018-0013-z","volume":"6","author":"C Zuo","year":"2018","unstructured":"Zuo, C. et al. SHP2 regulates skeletal cell fate by modifying SOX9 expression and transcriptional activity. Bone Res 6, 12 (2018).","journal-title":"Bone Res"},{"key":"26750_CR27","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/jdv.14542","volume":"32","author":"JT Lear","year":"2018","unstructured":"Lear, J. T. et al. Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study. J. Eur. Acad. Dermatol. Venereol. 32, 372\u2013381 (2018).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"26750_CR28","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrrheum.2011.156","volume":"7","author":"R Lories","year":"2011","unstructured":"Lories, R. The balance of tissue repair and remodeling in chronic arthritis. Nat. Rev. Rheumatol. 7, 700\u2013707 (2011).","journal-title":"Nat. Rev. Rheumatol."},{"key":"26750_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14003-6","volume":"11","author":"MM Weivoda","year":"2020","unstructured":"Weivoda, M. M. et al. Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism. Nat. Commun. 11, 87 (2020).","journal-title":"Nat. Commun."},{"key":"26750_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/dgd.12203","volume":"7","author":"KY Tsang","year":"2015","unstructured":"Tsang, K. Y., Chan, D. & Cheah, K. S. Fate of growth plate hypertrophic chondrocytes: death or lineage extension? Dev. Growth Differ. 7, 179\u2013192 (2015).","journal-title":"Dev. Growth Differ."},{"key":"26750_CR31","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.4049\/jimmunol.1300832","volume":"191","author":"Q Luo","year":"2013","unstructured":"Luo, Q. et al. A novel disease-modifying antirheumatic drug, Iguratimod, ameliorates murine arthritis by blocking IL-17 signaling, distinct from Methotrexate and Leflunomide. J. Immunol. 191, 4969\u20134978 (2013).","journal-title":"J. Immunol."},{"key":"26750_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.canlet.2017.09.023","volume":"410","author":"J Al-Matouq","year":"2017","unstructured":"Al-Matouq, J. et al. Accumulation of cytoplasmic CDC25A in cutaneous squamous cell carcinoma leads to a dependency on CDC25A for cancer cell survival and tumor growth. Cancer Lett. 410, 41\u201349 (2017).","journal-title":"Cancer Lett."},{"key":"26750_CR33","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/dvg.20335","volume":"45","author":"MD Muzumdar","year":"2007","unstructured":"Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L. & Luo, L. A global double-fluorescent Cre reporter mouse. Genesis 45, 593\u2013605 (2007).","journal-title":"Genesis"},{"key":"26750_CR34","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/jbmr.2409","volume":"30","author":"Z Chen","year":"2015","unstructured":"Chen, Z., Yue, S. X., Zhou, G., Greenfield, E. M. & Murakami, S. ERK1 and ERK2 regulate chondrocyte terminal differentiation during endochondral bone formation. J. Bone Min. 30, 765\u2013774 (2015).","journal-title":"J. Bone Min."},{"key":"26750_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3389\/fimmu.2017.00343","volume":"8","author":"G Guittard","year":"2017","unstructured":"Guittard, G. et al. Unexpected cartilage phenotype in CD4-Cre-conditional SOS-deficient mice. Front. Immunol. 8, 343 (2017).","journal-title":"Front. Immunol."},{"key":"26750_CR36","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3389\/fimmu.2017.00482","volume":"8","author":"M Wehenkel","year":"2017","unstructured":"Wehenkel, M. et al. Extracellular signal-regulated kinase signaling in CD4-expressing cells inhibits osteochondromas. Front. Immunol. 8, 482 (2017).","journal-title":"Front. Immunol."},{"key":"26750_CR37","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3389\/fimmu.2017.01326","volume":"8","author":"SMS Miah","year":"2017","unstructured":"Miah, S. M. S. et al. Ptpn11 deletion in CD4(+) cells does not affect T cell development and functions but causes cartilage tumors in a T cell-independent manner. Front. Immunol. 8, 1326 (2017).","journal-title":"Front. Immunol."},{"key":"26750_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ccr.2008.01.027","volume":"13","author":"H Kimura","year":"2008","unstructured":"Kimura, H., Ng, J. M. & Curran, T. Transient inhibition of the Hedgehog pathway in young mice causes permanent defects in bone structure. Cancer Cell 13, 249\u2013260 (2008).","journal-title":"Cancer Cell"},{"key":"26750_CR39","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1136\/ard.2004.029710","volume":"64","author":"T Bardos","year":"2005","unstructured":"Bardos, T. et al. A longitudinal study on an autoimmune murine model of ankylosing spondylitis. Ann. Rheum. 64, 981\u2013987 (2005).","journal-title":"Ann. Rheum."},{"key":"26750_CR40","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nature11940","volume":"495","author":"KL Cooper","year":"2013","unstructured":"Cooper, K. L. et al. Multiple phases of chondrocyte enlargement underlie differences in skeletal proportions. Nature 495, 375\u2013378 (2013).","journal-title":"Nature"},{"key":"26750_CR41","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","volume":"377","author":"B Prakken","year":"2011","unstructured":"Prakken, B., Albani, S. & Martini, A. Juvenile idiopathic arthritis. Lancet 377, 2138\u20132149 (2011).","journal-title":"Lancet"},{"key":"26750_CR42","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00296-005-0080-5","volume":"26","author":"I Keles","year":"2006","unstructured":"Keles, I. et al. Familial Mediterranean fever and ankylosing spondylitis in a patient with juvenile idiopathic arthritis: a case report and review of the literature. Rheumatol. Int. 26, 846\u2013851 (2006).","journal-title":"Rheumatol. Int."},{"key":"26750_CR43","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1172\/JCI23738","volume":"115","author":"RJ Lories","year":"2005","unstructured":"Lories, R. J., Derese, I. & Luyten, F. P. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J. Clin. Invest 115, 1571\u20131579 (2005).","journal-title":"J. Clin. Invest"},{"key":"26750_CR44","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1136\/ard.2010.148262","volume":"71","author":"G Ruiz-Heiland","year":"2012","unstructured":"Ruiz-Heiland, G. et al. Blockade of the hedgehog pathway inhibits osteophyte formation in arthritis. Ann. Rheum. 71, 400\u2013407 (2012).","journal-title":"Ann. Rheum."},{"key":"26750_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12767-9","volume":"7","author":"L Wang","year":"2017","unstructured":"Wang, L. et al. SHP2 regulates the osteogenic fate of growth plate hypertrophic chondrocytes. Sci. Rep. 7, 12699 (2017).","journal-title":"Sci. Rep."},{"key":"26750_CR46","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1172\/JCI90193","volume":"127","author":"AT Egunsola","year":"2017","unstructured":"Egunsola, A. T. et al. Loss of DDRGK1 modulates SOX9 ubiquitination in spondyloepimetaphyseal dysplasia. J. Clin. Invest 127, 1475\u20131484 (2017).","journal-title":"J. Clin. Invest"},{"key":"26750_CR47","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/art.30261","volume":"63","author":"TT Glant","year":"2011","unstructured":"Glant, T. T. et al. Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB\/c mice resembling two subtypes of rheumatoid arthritis. Arthritis Rheumatol. 63, 1312\u20131321 (2011).","journal-title":"Arthritis Rheumatol."},{"key":"26750_CR48","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1084\/jem.182.4.1153","volume":"182","author":"SD Khare","year":"1995","unstructured":"Khare, S. D., Luthra, H. S. & David, C. S. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies. J. Exp. Med 182, 1153\u20131158 (1995).","journal-title":"J. Exp. Med"},{"key":"26750_CR49","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1002\/j.1460-2075.1991.tb04978.x","volume":"10","author":"J Keffer","year":"1991","unstructured":"Keffer, J. et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 10, 4025\u20134031 (1991).","journal-title":"EMBO J."},{"key":"26750_CR50","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1242\/dev.128.24.5099","volume":"128","author":"F Long","year":"2001","unstructured":"Long, F., Zhang, X. M., Karp, S., Yang, Y. & McMahon, A. P. Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation. Development 128, 5099\u20135108 (2001).","journal-title":"Development"},{"key":"26750_CR51","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13075-015-0675-5","volume":"17","author":"J Bleil","year":"2015","unstructured":"Bleil, J. et al. Cartilage in facet joints of patients with ankylosing spondylitis (AS) shows signs of cartilage degeneration rather than chondrocyte hypertrophy: implications for joint remodeling in AS. Arthritis Res. Ther. 17, 170 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"26750_CR52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11926-017-0644-x","volume":"19","author":"MN Magrey","year":"2017","unstructured":"Magrey, M. N. & Khan, M. A. The paradox of bone formation and bone loss in ankylosing spondylitis: evolving new concepts of bone formation and future trends in management. Curr. Rheumatol. Rep. 19, 17 (2017).","journal-title":"Curr. Rheumatol. Rep."},{"key":"26750_CR53","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1136\/ard.53.2.117","volume":"53","author":"S Donnelly","year":"1994","unstructured":"Donnelly, S. et al. Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann. Rheum. 53, 117\u2013121 (1994).","journal-title":"Ann. Rheum."},{"key":"26750_CR54","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.4049\/jimmunol.1201006","volume":"189","author":"X Wu","year":"2012","unstructured":"Wu, X. et al. Selective sequestration of STAT1 in the cytoplasm via phosphorylated SHP-2 ameliorates murine experimental colitis. J. Immunol. 189, 3497\u20133507 (2012).","journal-title":"J. Immunol."},{"key":"26750_CR55","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.chom.2018.03.002","volume":"23","author":"A Staffas","year":"2018","unstructured":"Staffas, A. et al. Nutritional support from the intestinal microbiota improves hematopoietic reconstitution after bone marrow transplantation in mice. Cell host microbe 23, 447\u2013457.e444 (2018).","journal-title":"Cell host microbe"},{"key":"26750_CR56","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/978-1-62703-989-5_20","volume":"1130","author":"AJ Mirando","year":"2014","unstructured":"Mirando, A. J., Dong, Y., Kim, J. & Hilton, M. J. Isolation and culture of murine primary chondrocytes. Methods Mol. Biol. 1130, 267\u2013277 (2014).","journal-title":"Methods Mol. Biol."},{"key":"26750_CR57","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nprot.2008.95","volume":"3","author":"M Gosset","year":"2008","unstructured":"Gosset, M., Berenbaum, F., Thirion, S. & Jacques, C. Primary culture and phenotyping of murine chondrocytes. Nat. Protoc. 3, 1253\u20131260 (2008).","journal-title":"Nat. Protoc."},{"key":"26750_CR58","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1359\/jbmr.1997.12.8.1174","volume":"12","author":"C Shukunami","year":"1997","unstructured":"Shukunami, C. et al. Cellular hypertrophy and calcification of embryonal carcinoma-derived chondrogenic cell line ATDC5 in vitro. J. Bone Miner. Res 12, 1174\u20131188 (1997).","journal-title":"J. Bone Miner. Res"},{"key":"26750_CR59","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1172\/JCI35243E1","volume":"118","author":"Y Kawasaki","year":"2008","unstructured":"Kawasaki, Y. et al. Phosphorylation of GSK-3beta by cGMP-dependent protein kinase II promotes hypertrophic differentiation of murine chondrocytes. J. Clin. Invest 118, 2506\u20132515 (2008).","journal-title":"J. Clin. Invest"},{"key":"26750_CR60","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bcp.2016.06.001","volume":"115","author":"F Shao","year":"2016","unstructured":"Shao, F. et al. Andrographolide alleviates imiquimod-induced psoriasis in mice via inducing autophagic proteolysis of MyD88. Biochem. Pharmacol. 115, 94\u2013103 (2016).","journal-title":"Biochem. Pharmacol."}],"updated-by":[{"DOI":"10.1038\/s41467-025-56680-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26750-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26750-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26750-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T07:09:39Z","timestamp":1738998579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26750-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,11]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["26750"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-26750-6","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41467-025-56680-6","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,11]]},"assertion":[{"value":"8 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-025-56680-6","URL":"https:\/\/doi.org\/10.1038\/s41467-025-56680-6","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.S. and Q.X. have a patent pending on use of sonidegib in ankylosing spondylitis. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6540"}}